NCT01666509View on ClinicalTrials.gov

Efficacy and Tolerability of Topical Rossoseq™ Compared to Vehicle in Rosacea Subtype 1 (Erythematotelangiectatic)

NACompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

July 31, 2012

Primary Completion Date

December 31, 2012

Study Completion Date

December 31, 2012

Conditions

Rosacea Subtype 1 (Erythematotelangiectatic)

Interventions

DEVICE

Rossoseq™

DEVICE

Placebo

Trial Locations (4)

Unknown

Study site 5, Bochum

Study site 2, Dülmen

Study Site 1, Münster

Study site 4, Paderborn

All Listed Sponsors

lead

PBB Entrepreneur Ltd.

INDUSTRY

NCT01666509 - Efficacy and Tolerability of Topical Rossoseq™ Compared to Vehicle in Rosacea Subtype 1 (Erythematotelangiectatic) | Biotech Hunter | Biotech Hunter